Cargando…
Large variation in conservative management of low‐risk prostate cancer in Australia and New Zealand
Autores principales: | Ong, Wee Loon, Thangasamy, Isaac, Murphy, Declan, Pritchard, Elizabeth, Evans, Susan, Millar, Jeremy, Chalasani, Venu, Rashid, Prem, Winter, Matthew, Vela, Ian, Pryor, David, Mark, Stephen, Lawrentschuk, Nathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303782/ https://www.ncbi.nlm.nih.gov/pubmed/35076135 http://dx.doi.org/10.1111/bju.15698 |
Ejemplares similares
-
High prostate‐specific membrane antigen (PSMA) positron emission tomography (PET) maximum standardized uptake value in men with PI‐RADS score 4 or 5 confers a high probability of significant prostate cancer
por: Ptasznik, Gideon, et al.
Publicado: (2022) -
Prostate cancer survivorship care: if not now, when?
por: Dunn, Jeffrey, et al.
Publicado: (2021) -
Pathological predictors of (18)F‐DCFPyL prostate‐specific membrane antigen‐positive recurrence after radical prostatectomy
por: Perry, Elisa, et al.
Publicado: (2022) -
The safety of surgical mesh: what is online video content teaching our patients?
por: Parkin, Cameron James, et al.
Publicado: (2022) -
Prostate cancer survivorship essentials framework: guidelines for practitioners
por: Dunn, Jeff, et al.
Publicado: (2020)